137 related articles for article (PubMed ID: 14599723)
1. Natural killer cell functions mediated by the neuropeptide substance P.
Feistritzer C; Clausen J; Sturn DH; Djanani A; Gunsilius E; Wiedermann CJ; Kähler CM
Regul Pept; 2003 Nov; 116(1-3):119-26. PubMed ID: 14599723
[TBL] [Abstract][Full Text] [Related]
2. Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
Monaco-Shawver L; Schwartz L; Tuluc F; Guo CJ; Lai JP; Gunnam SM; Kilpatrick LE; Banerjee PP; Douglas SD; Orange JS
J Leukoc Biol; 2011 Jan; 89(1):113-25. PubMed ID: 20940324
[TBL] [Abstract][Full Text] [Related]
3. Regulation of NK92-MI cell cytotoxicity by substance P.
Fu WX; Qin B; Zhou AP; Yu QY; Huang QJ; Liang ZF
Scand J Immunol; 2011 Aug; 74(2):107-13. PubMed ID: 21375557
[TBL] [Abstract][Full Text] [Related]
4. Substance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cells.
Gallicchio M; Rosa AC; Benetti E; Collino M; Dianzani C; Fantozzi R
Br J Pharmacol; 2006 Mar; 147(6):681-9. PubMed ID: 16432508
[TBL] [Abstract][Full Text] [Related]
5. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
6. Substance P induction of murine keratinocyte PAM 212 interleukin 1 production is mediated by the neurokinin 2 receptor (NK-2R).
Song IS; Bunnett NW; Olerud JE; Harten B; Steinhoff M; Brown JR; Sung KJ; Armstrong CA; Ansel JC
Exp Dermatol; 2000 Feb; 9(1):42-52. PubMed ID: 10688374
[TBL] [Abstract][Full Text] [Related]
7. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
[TBL] [Abstract][Full Text] [Related]
8. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
9. Substance P regulates natural killer cell interferon-gamma production and resistance to Pseudomonas aeruginosa infection.
Lighvani S; Huang X; Trivedi PP; Swanborg RH; Hazlett LD
Eur J Immunol; 2005 May; 35(5):1567-75. PubMed ID: 15832292
[TBL] [Abstract][Full Text] [Related]
10. Identification of both NK1 and NK2 receptors in guinea-pig airways.
McKee KT; Millar L; Rodger IW; Metters KM
Br J Pharmacol; 1993 Oct; 110(2):693-700. PubMed ID: 7694756
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
Juszczak M
Neuro Endocrinol Lett; 2005 Aug; 26(4):367-72. PubMed ID: 16136007
[TBL] [Abstract][Full Text] [Related]
12. Differential role of neurokinin receptors in human lymphocyte and monocyte chemotaxis.
Hood VC; Cruwys SC; Urban L; Kidd BL
Regul Pept; 2000 Dec; 96(1-2):17-21. PubMed ID: 11102647
[TBL] [Abstract][Full Text] [Related]
13. The tachykinin NK1 receptor mediates the migration-promoting effect of substance P on human skin fibroblasts in culture.
Parenti A; Amerini S; Ledda F; Maggi CA; Ziche M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):475-81. PubMed ID: 8740139
[TBL] [Abstract][Full Text] [Related]
14. Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines.
Robertson MJ; Williams BT; Christopherson K; Brahmi Z; Hromas R
Cell Immunol; 2000 Jan; 199(1):8-14. PubMed ID: 10675270
[TBL] [Abstract][Full Text] [Related]
15. Substance P induces expression of the corticotropin-releasing factor receptor 1 by activation of the neurokinin-1 receptor.
Hamke M; Herpfer I; Lieb K; Wandelt C; Fiebich BL
Brain Res; 2006 Aug; 1102(1):135-44. PubMed ID: 16806114
[TBL] [Abstract][Full Text] [Related]
16. Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responses.
Tsuchida H; Takahashi S; Nosaka E; Mukaiyama O; Yamashita M; Morimoto K
Eur J Pharmacol; 2008 May; 586(1-3):306-12. PubMed ID: 18353309
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide signaling through neurokinin-1 and neurokinin-2 receptors augments antigen presentation by human dendritic cells.
Ohtake J; Kaneumi S; Tanino M; Kishikawa T; Terada S; Sumida K; Masuko K; Ohno Y; Kita T; Iwabuchi S; Shinohara T; Tanino Y; Takemura T; Tanaka S; Kobayashi H; Kitamura H
J Allergy Clin Immunol; 2015 Dec; 136(6):1690-1694. PubMed ID: 26371842
[No Abstract] [Full Text] [Related]
18. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
19. Evidence that tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitation and contraction in the circular muscle of guinea-pig duodenum.
Zagorodnyuk V; Santicioli P; Maggi CA; Giachetti A
Br J Pharmacol; 1995 May; 115(2):237-46. PubMed ID: 7545517
[TBL] [Abstract][Full Text] [Related]
20. Substance P and neurokinin A mediate sensory synaptic transmission in young rat dorsal horn neurons.
Li P; Zhuo M
Brain Res Bull; 2001 Jul; 55(4):521-31. PubMed ID: 11543953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
